News Archive: Manitoba’s Life Sciences

Life Science Association of Manitoba Newsletter: October 31, 2011

Life Science Association of Manitoba Newsletter: October 31, 2011

Includes: BIOFIBE 2011 Conference brings together industry leaders; Cangene earnings down to $1.5M: As firm focus on developing in house sales force and seeks acquisitions; Hospitals get new diagnostic tools: Province allocates $120M over 4 years; A chance to fix our broken R&D model; and more. [Click on Pic to learn more]

read more
Life Science Association of Manitoba Newsletter: October 31, 2011

Life Science Association of Manitoba Newsletter: October 3, 2011

Includes: Governments of Canada and Saskatchewan Support Development of New Environmental Technology, Restructured drug developer Medicure says it has enough revenue to continue,
Lilly expands open-innovation efforts with new drug discovery platform, First published papers on IMRIS suites report positive results, and more. [Click on Logo to learn more]

read more
Life Science Association of Manitoba Newsletter: October 31, 2011

Life Science Association of Manitoba Newsletter: September 6, 2011

Includes: The Life Science Association of Manitoba is pleased to announce the nominees for Company of the Year: Conviron, GlaxoSmithKline, Pfizer, RANA Respiratory Care Group , and Vita Health Products Inc.; Kane Biotech files new patent on bone tissue regeneration invention; and much more. [Click on Logo to learn more]

read more
Life Science Association of Manitoba Newsletter: October 31, 2011

Cangene Names John A. Sedor as President and Chief Executive Officer

“John’s appointment is the culmination of a rigorous and thoughtful search process over the past six months,” says board chair, Craig Baxter. “We believe he is the ideal CEO for the Company. He is a visionary leader and strong manager who brings a successful track record of growing companies and efficiently managing them to create value for shareholders, customers, partners and employees.” [Click on Logo to learn more]

read more